Skip to main content
Figure 2 | BMC Nephrology

Figure 2

From: Trends in anemia management in US hemodialysis patients 2004–2010

Figure 2

Multivariable adjusted iron doses and markers of iron stores 2004-2010 among patients 0–3, 4–6, and 7–18 months on dialysis. Panel (a) Monthly iron dose (mg); Panel (b) Serum ferritin (ng/ml); Panel (c) TSat (%). Values are based on white males greater than 65 years old with diabetes as the cause of ESRD. The slopes represent monthly rates of change for each of the three time periods (2004–2006, 2007–2009 and 2010). The “*” indicate that the slope is significantly different from 0. The grey dotted lines are 95% confidence intervals for the predicted values. The difference in slopes between 2004–2006 and 2007–2009 and between 2007–2009 and 2010 are statistically significant within each ‘time on dialysis’ subgroup for each of the parameters except for the comparisons of monthly iron dose in the 0–3 month subgroup between 2007–2009 and 2010, and ferritin in the 0–3 month subgroup between 2004–2006 and 2007–2009.

Back to article page